M-M-RVaxPro is a vaccine used to protect adults and children aged 12 months or older against measles, mumps, and rubella (German measles). Under some special circumstances, it can also be used in babies as young as nine months. M-M-RVaxPro contains live attenuated (weakened) measles, mumps and rubella viruses. How is M-M-RVaxPro used?

M-M-RvaxPro is indicated for simultaneous vaccination against measles, mumps and rubella in individuals from 12 months of age (see section 4.2). M-M-RvaxPro can be administered to infants from 9 months of age under special circumstances (see sections 4.2, 4.4 and 5.1).

2025年2月4日 · Studies have shown that breast‑feeding postpartum women vaccinated with live attenuated rubella vaccines may secrete the virus in breast milk and transmit it to breast‑fed infants. In the infants with serological evidence of rubella …

Po podaní imunitný systém vytvorí protilátky proti týmto vírusom a chráni telo pred infekciami, ktoré spôsobujú. Podáva sa: u doposiaľ neočkovaných osôb starších ako 9 mesiacov, ktoré sú v kontakte s vnímavými tehotnými ženami a u osôb, ktoré sú pravdepodobne vnímavé na mumps a ružienku. Dávkovanie a dávkovacie schémy.

2024年8月31日 · M-M-RVAXPRO est indiqué pour la prévention conjointe de la rougeole, des oreillons, et de la rubéole chez les sujets dès l'âge de 12 mois (voir la rubrique "Posologie").

M-M-RVAXPRO este un vaccin care conţine virusuri atenuate rujeolic, urlian şi rubeolic. Când se administrează vaccinul unei persoane, sistemul imunitar (sistemul natural de apărare al organismului) va produce anticorpi împotriva virusurilor rujeolei, oreionului şi rubeolei.

M-M-RvaxPro may be given with some routine childhood vaccines that may be due to be given at the same time. For vaccines that cannot be given at the same time, M-M-RvaxPro should be given 1 month before or after administration of those vaccines.

M-M-RvaxPro ist ein Impfstoff mit abgeschwächten Masern-, Mumps- und Röteln-Viren. Nach der Verabreichung des Impfstoffs bildet das Immunsystem (das natürliche Abwehrsystem des Körpers) Antikörper gegen Masern-, Mumps- und Röteln-Viren. Diese Antikörper schützen vor Infektionen, die durch diese Viren verursacht werden.

CDC recommends that people get MMR vaccine to protect against measles, mumps, and rubella. Children should get two doses of MMR vaccine, starting with the first dose at 12 to 15 months of age, and the second dose at 4 through 6 years of age. Teens and adults should also be up to date on their MMR vaccination.

M-M-RvaxPro är ett vaccin innehållande mässling-, påssjuke- och röda hundvirus som har försvagats. När vaccinet ges till en person kommer immunsystemet (kroppens naturliga försvarssystem) att tillverka antikropp ar mot mässling-, påssjuke- och röda hundvirus. Antikropp arna hjälper till att försvara mot infektion er orsakade av dessa virus.